Association between enhanced soluble CD40 ligand and prothrombotic state in inflammatory bowel disease

被引：0
|
作者：
Koutroubakis, IE
Theodoropoulou, A
Xidakis, C
Sfiridaki, A
Notas, G
Kolios, G
Kouroumalis, E
机构：
来源：
GASTROENTEROLOGY | 2004年 / 126卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A206 / A206
页数：1
相关论文
共 50 条
  • [21] CD40-dependent inflammatory and thrombogenic responses to soluble CD40 ligand in the microvasculature
    Stokes, KY
    Gurwara, S
    Granger, DN
    FASEB JOURNAL, 2006, 20 (04): : A704 - A704
  • [22] No link between soluble CD40 ligand and subclinical atherosclerosis
    Claire Braybrook
    Nature Clinical Practice Cardiovascular Medicine, 2005, 2 (11): : 556 - 557
  • [23] The CD40/CD40L costimulatory pathway in inflammatory bowel disease
    Danese, S
    Sans, M
    Fiocchi, C
    GUT, 2004, 53 (07) : 1035 - 1043
  • [24] Expression of CD40 and CD40L in inflammatory bowel disease.
    Liu, Z
    Colpaert, S
    Van den Broeck, C
    D'Haens, G
    Ceuppens, J
    Geboes, K
    Rutgeerts, P
    GASTROENTEROLOGY, 1998, 114 (04) : A1024 - A1024
  • [25] Enhanced soluble CD40 ligand and Alzheimer's disease: Evidence of a possible pathogenetic role
    Desideri, Giovambattista
    Cipollone, Francesco
    Necozione, Stefano
    Marini, Carmine
    Lechiara, Maria Carmela
    Taglieri, Guglielmo
    Zuliani, Giovanni
    Fellin, Renato
    Mezzetti, Andrea
    Di Orio, Ferdinando
    Ferri, Claudio
    NEUROBIOLOGY OF AGING, 2008, 29 (03) : 348 - 356
  • [26] Association between serum soluble CD40 ligand levels and mortality in patients with severe sepsis
    Lorente, Leonardo
    Martin, Maria M.
    Varo, Nerea
    Maria Borreguero-Leon, Juan
    Sole-Violan, Jordi
    Blanquer, Jose
    Labarta, Lorenzo
    Diaz, Cesar
    Jimenez, Alejandro
    Pastor, Eduardo
    Belmonte, Felipe
    Orbe, Josune
    Rodriguez, Jose A.
    Gomez-Melini, Eduardo
    Ferrer-Agueero, Jose M.
    Ferreres, Jose
    LLiminana, Maria C.
    Paramo, Jose A.
    CRITICAL CARE, 2011, 15 (02)
  • [27] Association between serum soluble CD40 ligand levels and mortality in patients with severe sepsis
    Leonardo Lorente
    María M Martín
    Nerea Varo
    Juan María Borreguero-León
    Jordi Solé-Violán
    José Blanquer
    Lorenzo Labarta
    César Díaz
    Alejandro Jiménez
    Eduardo Pastor
    Felipe Belmonte
    Josune Orbe
    José A Rodríguez
    Eduardo Gómez-Melini
    José M Ferrer-Agüero
    José Ferreres
    María C LLimiñana
    José A Páramo
    Critical Care, 15
  • [28] Association between soluble CD40 ligand and subclinical atherosclerosis in patients with systemic lupus erythematosus
    Nassonov, E. L.
    Popkova, T. V.
    Ilina, A. E.
    Klioukvina, N. G.
    Panafidina, T. A.
    Alexandrova, E. N.
    Novikov, A. A.
    Novikova, D. S.
    Mach, E. S.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 462 - 462
  • [29] Developmental changes in soluble CD40 ligand
    Cholette, Jill M.
    Blumberg, Neil
    Phipps, Richard P.
    Mcdermott, Michael P.
    Gettings, Kelly F.
    Lerner, Norma B.
    JOURNAL OF PEDIATRICS, 2008, 152 (01): : 50 - 54
  • [30] Activated platelets are the source of elevated levels of soluble (S) CD40 ligand (L) in the circulation of inflammatory bowel disease (IBD) patients
    Danese, S
    Katz, J
    Saibeni, S
    Papa, A
    Gasbarrini, A
    Vecchi, M
    Fiocchi, C
    GASTROENTEROLOGY, 2003, 124 (04) : A73 - A73
12345